Optum guides members and providers through important upcoming formulary updates. See multiple tabs of linked spreadsheet for Select, Premium & UM Changes.
Cassipa® (buprenorphine/naloxone) – New drug approval
September 7, 2018 - The FDA announced the approval of Teva’s Cassipa (buprenorphine/naloxone) sublingual film, for the maintenance treatment of opioid dependence.
